Literature DB >> 16351773

Effect of apolipoprotein E genotype on vitamin K status in healthy older adults from China and the UK.

Liya Yan1, Bo Zhou, Shailja Nigdikar, Xiaohong Wang, Janet Bennett, Ann Prentice.   

Abstract

The vitamin K concentration in the circulation and the availability of vitamin K to bone may be affected by factors influencing lipoprotein metabolism, such as apoE genotype. The relationships between markers of vitamin K status, bone mineral content and apoE genotype were studied in healthy older men and women aged 60-83 years, 177 from Shenyang, China, and 132 from Cambridge, UK. Fasting plasma was analysed for vitamin K1, triacylglycerol, total osteocalcin, undercarboxylated osteocalcin (ucOC) and apoE genotype. Hip bone mineral content was measured using dual-energy X-ray absorptiometry. Subjects were grouped according to apoE genotype as E2/3, E3/3 and [E3/4+E4/4]. The mean plasma vitamin K1 concentration of the three genotype groups was significantly higher and the percentage ucOC was lower in the Chinese than in the British subjects (P<0.01). A higher vitamin K1 concentration was found in subjects with [E3/4+E4/4] than those with either E2/3 or E3/3 in Cambridge (32.2 (SE 14.6 ) %, P=0.03; 24.6 (SE 10.7 ) %, P=0.02). Similar trends were observed although were not statistically significant in Shenyang (26.5 (18.9) %, P=0.16; 23.1 (13.0) %, P=0.08). Subjects with [E3/4+E4/4] had a lower percentage ucOC (total osteocalcin adjusted) than did those with either E2/3 or E3/3 in Shenyang (65.1 (27.2) %, P=0.02; 49.6 (19.9) %, P=0.01 respectively) but not in Cambridge. This study demonstrates that a superior vitamin K status is associated with the apoE4 genotype in healthy older individuals from China and the UK.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16351773     DOI: 10.1079/bjn20051578

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  7 in total

1.  Does the geographical gradient of ApoE4 allele exist in China? A systemic comparison among multiple Chinese populations.

Authors:  Peng Hu; Yuan Han Qin; Cheng Xue Jing; Ling Lu; Bo Hu; Peng Fei Du
Journal:  Mol Biol Rep       Date:  2010-03-31       Impact factor: 2.316

2.  Meta-analysis of genome-wide association studies for circulating phylloquinone concentrations.

Authors:  Hassan S Dashti; M Kyla Shea; Caren E Smith; Toshiko Tanaka; Adela Hruby; Kris Richardson; Thomas J Wang; Mike A Nalls; Xiuqing Guo; Yongmei Liu; Jie Yao; Dalin Li; W Craig Johnson; Emelia J Benjamin; Stephen B Kritchevsky; David S Siscovick; José M Ordovás; Sarah L Booth
Journal:  Am J Clin Nutr       Date:  2014-10-08       Impact factor: 7.045

Review 3.  Vitamin K nutrition, metabolism, and requirements: current concepts and future research.

Authors:  Martin J Shearer; Xueyan Fu; Sarah L Booth
Journal:  Adv Nutr       Date:  2012-03-01       Impact factor: 8.701

4.  Vitamins K and D status in stages 3-5 chronic kidney disease.

Authors:  Rachel M Holden; A Ross Morton; Jocelyn S Garland; Andrey Pavlov; Andrew G Day; Sarah L Booth
Journal:  Clin J Am Soc Nephrol       Date:  2010-02-18       Impact factor: 8.237

5.  Biological Systems of Vitamin K: A Plasma Nutriproteomics Study of Subclinical Vitamin K Deficiency in 500 Nepalese Children.

Authors:  Sun Eun Lee; Kerry J Schulze; Robert N Cole; Lee S F Wu; James D Yager; John Groopman; Parul Christian; Keith P West
Journal:  OMICS       Date:  2016-02-25

Review 6.  Vitamin Pharmacogenomics: New Insight into Individual Differences in Diseases and Drug Responses.

Authors:  Hai-Yan He; Mou-Ze Liu; Yue-Li Zhang; Wei Zhang
Journal:  Genomics Proteomics Bioinformatics       Date:  2017-04-01       Impact factor: 7.691

7.  Causal association of circulating cholesterol levels with dementia: a mendelian randomization meta-analysis.

Authors:  Xiaoyu Zhang; Qiuyue Tian; Di Liu; Tao Geng; Xizhu Xu; Siqi Ge; Deqiang Zheng; Lijuan Wu; Manshu Song; Haifeng Hou; Wei Wang; Youxin Wang
Journal:  Transl Psychiatry       Date:  2020-05-12       Impact factor: 6.222

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.